Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Bannish, Brittany E ^a   Chernysh, Irina N ^b   Keener, James P ^c   Fogelson, Aaron L ^c   Weisel, John W ^b  

^a UNIVERSITY OF CENTRAL OKLAHOMA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; TISSUE PLASMINOGEN ACTIVATOR;

FIBRINOLYSIS; HUMAN; KINETICS; METABOLISM; THEORETICAL MODEL;

FIBRINOLYSIN; FIBRINOLYSIS; HUMANS; KINETICS; MODELS, THEORETICAL; TISSUE PLASMINOGEN ACTIVATOR;

EID: 85027252829     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-06383-w     Document Type: Article

References (47)

1. Mutch, N. J. & Booth, N. A. Plasminogen activation and regulation of fibrinolysis. In Marder, V. J. & et al. (eds) Hemostasis and Thrombosis: Basic Principles and Clinical Practice 314-333 (Lippincott Williams & Wilkins, Philadelphia, sixth edn 2013)
2. Collet, J. P. et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: Dynamic and structural approaches by confocal microscopy. Arterioscler. Thromb. Vasc. Biol. 20, 1354-1361 (2000)
3. Blinc, A., Magdic, J., Fric, J. & Musevic, I. Atomic force microscopy of fibrin networks and plasma clots during fibrinolysis. Fibrinolysis Proteol. 14, 288-299 (2000)
4. Veklich, Y., Francis, C. W., White, J. & Weisel, J. W. Structural studies of fibrinolysis by electron microscopy. Blood 92, 4721-4729 (1998)
5. Weisel, J. W. Fibrinogen and fibrin. Adv. Protein Chem. 70, 247-299 (2005)
6. Weisel, J. W., Veklich, Y., Collet, J. P. & Francis, C. W. Structural studies of fibrinolysis by electron and light microscopy. Thromb. Haemost. 82, 277-282 (1999)
7. Longstaff, C. & Kolev, K. Basic mechanisms and regulation of fibrinolysis. J. Thromb. Haemost. 13, S98-S105 (2015)
8. Blombäck, B., Carlsson, K., Fatah, K., Hessel, B. & Procyk, R. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb. Res. 75, 521-538 (1994)
9. Campbell, R. A., Obermyer, K. A., Bagnell, C. R. & Wolberg, A. S. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler. Thromb. Vasc. Biol. 28, 2247-2254 (2008)
10. Ryan, E. A., Mockros, L. F., Weisel, J. W. & Lorand, L. Structural origins of fibrin clot rheology. Biophys. J. 77, 2813-2826 (1999)
11. Collet, J. P., Lesty, C., Montalescot, G. & Weisel, J. W. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J. Biol. Chem. 278, 21331-21335 (2003)
12. Collet, J. P. et al. Dusart syndrome: A new concept of the relationship between fibrin clot architecture and fibrin clot degradability: Hypofibrinolysis related to an abnormal clot structure. Blood 82, 2462-2469 (1993)
13. Carr, M. E. & Alving, B. M. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots. Blood Coagul. Fibrinolysis 6, 567-573 (1995)
14. Diamond, S. L. & Anand, S. Inner clot diffusion and permeation during fibrinolysis. Biophys. J. 65, 2622-2643 (1993)
15. Wu, J. H., Siddiqui, K. & Diamond, S. L. Transport phenomena and clot dissolving therapy: An experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis. Thromb. Haemost. 72, 105-112 (1994)
16. Kolev, K., Tenekedjiev, K., Komorowicz, E. & Machovich, R. Functional evalutaion of the structural features of proteases and their substrate in fibrin surface degradation. J. Biol. Chem. 272, 13666-13675 (1997)
17. Carr, M. E. & Hermans, J. Size and density of fibrin fibers from turbidity. Macromolecules 11, 46-50 (1978)
18. Voter, W. A., Lucaveche, C. & Erickson, H. P. Concentration of protein in fibrin fibers and fibrinogen polymers determined by refractive index matching. Biopolymers 25, 2375-2384 (1986)
19. Weisel, J. W. & Litvinov, R. I. The biochemical and physical process of fibrinolysis and effects of clot structure and stability on the lysis rate. Cardiovasc. Hematol. Agents Med. Chem. 6, 161-180 (2008)
20. Bannish, B. E., Keener, J. P. & Fogelson, A. L. Modelling fibrinolysis: a 3D stochastic multiscale model. Math. Med. Biol. 31, 17-44 (2014)
21. Gillespie, D. T. A general method for numerically simulating the stochastic time evolution of coupled chemical reactions. J. Comput. Phys. 22, 403-434 (1976)
22. Gillespie, D. T. Exact stochastic simulation of coupled chemical reactions. Journal of Physical Chemistry 81, 2340-2361 (1977)
23. Diamond, S. L. Engineering design of optimal strategies for blood clot dissolution. Annu. Rev. Biomed. Eng. 1, 427-461 (1999)
24. Rathore, Y. S., Rehan, M., Pandey, K., Sahni, G. & Ashish, J. First structural model of full-length human tissue-plasminogen activator: a saxs data-based modeling study. J. Phys. Chem. B 116, 496-502 (2012)
25. Xue, Y., Bodin, C. & Olsson, K. Crystal structure of the native plasminogen reveals an activation-resistant compact conformation. J. Thromb. Haemost. 10, 1385-1396 (2012)
26. Weisel, J. W., Nagaswami, C., Korsholm, B., Peterson, L. C. & Suenson, E. Interaction of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy. J. Mol. Biol. 235, 1117-1135 (1994)
27. Christiansen, V. J., Jackson, K. W., Lee, K. N. & McKee, P. A. The effect of a single nucleotide polymorphism on human α2-antiplasmin activity. Blood 109, 5286-5292 (2007)
28. Wiman, B. & Collen, D. On the kinetics of the reaction between human antiplasmin and plasmin. Eur. J. Biochem. 84, 573-578 (1978)
29. Lee, K. N., Jackson, K. W., Christiansen, V. J., Chung, K. H. & McKee, P. A. α2-antiplasmin: Potential therapeutic roles in fibrin survival and removal. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2, 303-310 (2004)
30. Ho-Tin-Noé, B., Rojas, G., Vranckx, R., Lijnen, H. R. & Anglés-Cano, E. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis. FEBS J. 272, 3387-3400 (2005)
31. Silvain, J. et al. Composition of coronary thrombus in acute myocardial infarction. J. Am. Coll. Cardiol. 57, 1359-1367 (2011)
32. Kovacs, A. et al. Ultrastructure and composition of thrombi in coronary and peripheral artery disease: correlations with clinical and laboratory findings. Thromb. Res. 135, 760-766 (2015)
33. Marder, V. J. et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 37, 2086-2093 (2006)
34. Kesieme, E., Kesieme, C., Jebbin, N., Irekpita, E. & Dongo, A. Deep vein thrombosis: a clinical review. J. Blood. Med. 2, 59-69 (2011)
35. Tanswell, P. et al. Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. J. Am. Coll. Cardiol. 19, 1071-1075 (1992)
36. Varjú, I. et al. Fractal kinetic behavior of plasmin on the surface of fibrin meshwork. Biochemistry 53, 6348-6356 (2014)
37. Fraser, S. R., Booth, N. A. & Nicola, N. J. The antifibrinolytic function of factor XIII is exclusively expressed through α2-antiplasmin cross-linking. Blood 117, 6371-6374 (2011)
38. Yang, Z., Mochalkin, I. & Doolittle, R. F. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc. Natl. Acad. Sci. USA 97, 14156-14161 (2000)
39. Anand, S., Wu, J. & Diamond, S. L. Enzyme-mediated proteolysis of fibrous biopolymers: Dissolution front movement in fibrin or collagen under conditions of diffusive or convective transport. Biotechnol. Bioeng. 48, 89-107 (1995)
40. Tanka-Salaman, A., Tenekedjiev, K., Machovich, R. & Kolev, K. Suppressed catalytic efficiency of plasmin in the presence of long-chain fatty acids. FEBS J. 275, 1274-1282 (2008)
41. Lucas, M. A., Fretto, L. J. & McKee, P. A. The binding of human plasminogen to fibrin and fibrinogen. J. Biol. Chem. 258, 4249-4256 (1983)
42. Sakharov, D. V. & Rijken, D. C. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 92, 1883-1890 (1995)
43. Wootton, D. M., Popel, A. S. & Alevriadou, B. R. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator. Biotechnol. Bioeng. 77, 405-419 (2002)
44. Bachmann, F. The plasminogen-plasmin enzyme system. In et al., R. C. (ed.) Hemostasis and Thrombosis: Basic Principles and Clinical Practice, chapter 84, 1592-1622 (J. B. Lippincott Company, Philadelphia, third edn 1994)
45. Horrevoets, A. J. G., Smilde, A., de Vries, C. & Pannekoek, H. The specific role of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis. J. Biol. Chem. 269, 12639-12644 (1994)
46. Hoylaerts, M., Rijken, D. C., Lijnen, H. R. & Collen, D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. J. Biol. Chem. 257, 2912-2919 (1982)
47. Norrman, B., Wallén, P. & Rånby, M. Fibrinolysis mediated by tissue plasminogen activator: Disclosure of a kinetic transition. Eur. J. Biochem. 149, 193-200 (1985).